Author Title [ Type(Desc)] Year
Filters: Author is Putter, Hein  [Clear All Filters]
Journal Article
von Asmuth EGJ, Putter H, Mohseny AB, Schilham MW, Snowden JA, Saccardi R, Lankester AC. Automating outcome analysis after stem cell transplantation: The YORT tool. Bone Marrow Transplant. 2023.
Saccardi R, Putter H, Eikema D-J, Busto MPaula, McGrath E, Middelkoop B, Adams G, Atlija M, Ayuk FAyuketang, Baldomero H, et al. Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE). Bone Marrow Transplant. 2023.
Brand R, Putter H, van Biezen A, Niederwieser D, Martino R, Mufti G, Onida F, Symeonidis A, Schmid C, Garderet L, et al. Comparison of Allogeneic Stem Cell Transplantation and Non-Transplant Approaches in Elderly Patients with Advanced Myelodysplastic Syndrome: Optimal Statistical Approaches and a Critical Appraisal of Clinical Results Using Non-Randomized Data. PLoS One. 2013;8(10):e74368.
Willemsen L, van der Zijde CMJol-, Admiraal R, Putter H, Jansen-Hoogendijk AM, Dam MMOstaijen, Wijnen JT, van Kesteren C, Waaijer JLM, Lankester AC, et al. Impact of serotherapy on immune reconstitution and survival outcomes after stem cell transplantations in children: thymoglobulin versus alemtuzumab. Biol Blood Marrow Transplant. 2014.
Koster EAS, Bonneville EF, Borne PA von dem, van Balen P, Marijt EWA, Tjon JML, Snijders TJF, van Lammeren D, Veelken H, Putter H, et al. Joint models quantify associations between immune cell kinetics and allo-immunological events after allogeneic stem cell transplantation and subsequent donor lymphocyte infusion. Front Immunol. 2023;14:1208814.
von Asmuth EGj, Neven B, Albert MH, Mohseny AB, Schilham MW, Binder H, Putter H, Lankester AC. Predicting patient death after allogeneic SCT for inborn errors using machine learning (PREPAD): An EBMT IEWP study. Transplant Cell Ther. 2023.
Vangangelt KMH, Green AR, Heemskerk IMF, Cohen D, van Pelt GW, Sobral-Leite M, Schmidt MK, Putter H, Rakha EA, Tollenaar RAEM, et al. The prognostic value of the tumor-stroma ratio is most discriminative in patients with grade III or triple negative breast cancer. Int J Cancer. 2020.
Verhoeven DHJ, Claas ECJ, van der Zijde CMJol-, Thijssen JCP, Lankester AC, Bredius RGM, Putter H, Kroes ACM, R Egeler M, Schilham MW, et al. Reactivation of Human Herpes Virus-6 after Pediatric Stem Cell Transplantation: Risk Factors, Onset, Clinical Symptoms and Association with Severity of Acute Graft-Versus-Host Disease. Pediatr Infect Dis J. 2015.